Seegene today announced the launch of the Global Million Clinical Study (GMCS), aiming to evaluate the clinical utility and ...

The COVID-19 pandemic led to many changes. Among them is universal familiarity with a molecular diagnostic technique that was largely unknown outside clinical use. The polymerase chain reaction — or ...

A cluster-randomized clinical trial finds that adoption of onsite polymerase chain reaction (PCR) testing for COVID-19, ...

Over the past four years, many of us have become accustomed to a swab up the nose to test for COVID-19, using at-home rapid antigen tests or the more accurate clinic-provided PCR tests with a longer ...

The COVID-19 pandemic yielded important advances in testing for respiratory viruses, but it also exposed important unmet needs in screening to prevent the spread of infections in high-risk settings.

Because of its high accuracy, laboratory-based polymerase chain reaction (PCR) testing is the gold standard for infectious disease diagnostics. However, PCR technology requires highly trained staff ...

Mérieux, a world leader in the field of in vitro diagnostics, today announces the launch of GENE-UP® PROBIOTIC SPECIES ID, a ...

A second test, which can take up to two weeks, will confirm where the live bacteria are coming from.

A new biotechnology company in McKinney has ambitions to become the world's first fully integrated platform for polymerase chain reaction (PCR) testing - the same technology behind a common COVID-19 ...

The use of point-of-care respiratory multiplex polymerase chain reaction (POC-RMPCR) in nursing homes did not affect the ...